Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ventyx Biosciences, Inc. Common Stock (NASDAQ: VTYX)

 
VTYX Technical Analysis
5
As on 24th Oct 2025 VTYX V- Price closed @ 5.81 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.34 & Strong Buy for SHORT-TERM with Stoploss of 3.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VTYXV- Price

Open 6.71 Change Price %
High 6.96 1 Day -0.79 -11.97
Low 5.74 1 Week 1.85 46.72
Close 5.81 1 Month 3.51 152.61
Volume 12428817 1 Year 1.20 26.03
52 Week High 5.28 | 52 Week Low 0.84
 
NASDAQ USA Most Active Stocks
BYND 2.19 -22.89%
AMRS 0.14 100.00%
WBA 11.98 0.50%
INTC 38.28 0.31%
OPEN 7.97 13.37%
NVDA 186.26 2.25%
LMDX 0.02 0.00%
BITF 4.61 10.55%
AKTS 0.04 0.00%
TSLA 433.72 -3.40%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
EGRX 1.00 900.00%
CTXRW 0.14 600.00%
ORGS 0.90 260.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
AXAS 0.03 -70.00%
 
 
VTYX
Daily Charts		 VTYX
Intraday Charts		 Whats New @
Bazaartrend		 VTYX
Free Analysis
 
VTYX Important Levels Intraday
RESISTANCE8.16
RESISTANCE7.41
RESISTANCE6.94
RESISTANCE6.47
SUPPORT5.15
SUPPORT4.68
SUPPORT4.21
SUPPORT3.46
 
VTYX Forecast October 2025
Share
4th UP Forecast8.58
3rd UP Forecast7.69
2nd UP Forecast7.14
1st UP Forecast6.59
1st DOWN Forecast5.03
2nd DOWN Forecast4.48
3rd DOWN Forecast3.93
4th DOWN Forecast3.04
 
VTYX Weekly Forecast
4th UP Forecast7.78
3rd UP Forecast7.15
2nd UP Forecast6.76
1st UP Forecast6.37
1st DOWN Forecast5.25
2nd DOWN Forecast4.86
3rd DOWN Forecast4.47
4th DOWN Forecast3.84
 
VTYX Forecast2025
4th UP Forecast19.38
3rd UP Forecast15.03
2nd UP Forecast12.34
1st UP Forecast9.65
1st DOWN Forecast1.97
2nd DOWN Forecast-0.72
3rd DOWN Forecast-3.41
4th DOWN Forecast-7.76
 
 
VTYX Other Details
Segment EQ
Market Capital 988394112.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VTYX Address
VTYX
 
VTYX Latest News
 
Your Comments and Response on Ventyx Biosciences, Inc. Common Stock
 
VTYX Business Profile
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that has completed phase I clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases. In addition, the company develops CNS-penetrant NLRP3 inhibitors. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service